Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study;Incidencia de la fibrilación auricular en los pacientes en hemodiálisis. Estudio prospectivo a largo plazo

Revista Espanola de Cardiologia

Volumn 59, Issue 8, 2006, Pages 779-784

  Vázquez Ruiz de Castroviejo, Eduardo ^a,c   Sánchez Perales, Carmen ^b   Lozano Cabezas, Cristóbal ^a   García Cortés, María José ^b   Guzmán Herrera, Manuel ^a   Borrego Utiel, Francisco ^b   López López, Juana ^a   Pérez Bañasco, Vicente ^b  

^a Servicio de Cardiologia   (Spain)

^b Servicio de Nefrología   (Spain)

^c NONE   (Spain)

Author keywords

Arrhythmia; Embolism; Kidney

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG USE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MORTALITY; PERITONEAL DIALYSIS; PREDICTION; RISK ASSESSMENT; SINUS RHYTHM; THROMBOEMBOLISM;

EID: 33749640319     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091881     Document Type: Article

References (25)

1. Alpert JS. Atrial fibrillation: a growth industry in the 21st century. Eur Heart J. 2000;21:1207-8.
2. Ezekowitz MD. Atrial fibrillation: the epidemic of the new millennium. Ann Intern Med. 1999;131:537-8.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention. The anticoagulation and risk factores in atrial fibrillation (ATRIA) study. JAMA. 2001;285:2370-5.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. The Framingham heart study. Circulation. 1998;98:946-52.
5. Stewart S, Carole LH, Hole DJ, McMurray JJV. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Oausket study. Am J Med. 2002;113:359-64.
6. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-8.
7. London GM, Marchais SJ, Guerin AP. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemdynamics factors. Kidney Int. 1993;43 Suppl 41:42-9.
8. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32 Suppl 3:184-99.
9. Vázquez E, Sánchez-Perales C, Borrego F, García-Cortés MJ, Lozano C, Guzmán M, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000;140:886-90.
10. Vázquez E, Sánchez-Perales C, Lozano C, García-Cortes MJ, Borrego F, Guzmán M, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol. 2003;92:868-71.
11. Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P. Incidence of stroke among chronic hemodialysis patients with non-rheumatic atrial fibrillation. Am J Nephrol. 2001;121:35-9.
12. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol. 2000;54:234-9.
13. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol. 2003;4:1.
14. Genovesi S, Pogliani D, Faini A, Valsechi MG, Riva A, Stefani F, et al. Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis. 2005;46:897-902.
15. Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. The ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2001;22:1852-923.
16. Patel PJ, Keating RJ, Gersh BJ, Hodge DO, Hammill SC, Shen WK. Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area. Am J Cardiol. 2004;94:1379-82.
17. Vidaillet H, Granada JF, Chyou PH, Maassen K, Ortiz M, Pulido JN, et al. A population-based study of mortality among patients with atrial fibrillation or flutter. Am J Med. 2002;113:365-70.
18. Sudlow M, Thomson R, Thwaites B. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167-71.
19. Feinberg WM, Blackshear JL, Laupacis A. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med. 1995;55:469-73.
20. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;47:1825-33.
21. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;47:1834-40.
22. Heras M, Fernández-Ortiz A, Gómez-Guindal JA, Iriarte JA, Lidón RM, Pérez-Gómez F, et al. Guías de actuación clínica de la Sociedad Española de Cardiología. Recomendaciones para el uso del tratamiento antitrombótico en cardiología. Rev Esp Cardiol. 1999:52:801-20.
23. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. 1993;44:1086-90.
24. Vázquez E, Sánchez-Perales C, García-Cortes MJ, Borrego F, Lozano C, Guzmán M, et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Intern J Cardiol. 2003;87:135-9.
25. Sánchez-Perales C, Vázquez E, García-Cortés MJ, Borrego FJ, Borrego J, Pérez del Barrio P, et al. Antiplatelet therapy and risk of bleeding in hemodialysis patients. Nefrología 2002;5: 456-62.